The scalp and hair follicles also undergo biological changes over time. However, saying that “hair falls out as we age” is not a sufficient explanation on its own. Age-related changes in hair density, hair-shaft diameter, pigmentation and the hair cycle are associated with multiple mechanisms, ranging from the stem-cell niche to the hormonal environment. Androgenetic alopecia, telogen effluvium and other hair disorders cannot be explained simply as “scalp aging.”
This guide focuses on Collagen XVII (COL17A1), the hair-follicle stem-cell niche and age-related follicle changes, while distinguishing well-supported findings from those that remain experimental.
What Is Collagen XVII?
Collagen XVII is a transmembrane protein encoded by the COL17A1 gene and is also known as BP180. In the skin and hair follicle, it forms part of hemidesmosomal structures that help connect cells to the basement membrane. In the hair follicle, the importance of Collagen XVII is not limited to mechanical adhesion; it is also associated with maintenance of the niche in which hair-follicle stem cells reside.
Current research indicates that Collagen XVII participates in niche signaling related to stem-cell adhesion, polarity and regenerative capacity. However, much of this biology comes from experimental models, and strong clinical evidence showing that permanently increasing Collagen XVII in humans reverses hair aging remains limited.
What Did the 2016 Science Study Show?
One of the key studies linking hair-follicle aging with Collagen XVII was published in Science in 2016. The study showed that a DNA-damage response in hair-follicle stem cells can lead to proteolysis of Collagen XVII, which was associated with loss of stem-cell characteristics and a shift toward epidermal differentiation.
The removal of aged stem cells from the follicular niche through terminal epidermal differentiation was associated with progressive follicle miniaturization in the experimental systems. COL17A1 deficiency recapitulated this aging phenotype, whereas experimental maintenance of COL17A1 suppressed the process.
This study is highly valuable for understanding the biology of hair-follicle aging, but its findings should not be interpreted as meaning that “if a cosmetic ingredient increases Collagen XVII, it will reverse an aged follicle.” An experimental mechanism and the clinical effect of a finished cosmetic product in humans are not the same level of evidence.
How Does the Hair-Follicle Stem-Cell Niche Change With Age?
Throughout life, the hair follicle renews cyclically through anagen, catagen and telogen phases. Hair-follicle stem cells and their surrounding niche work together in this regenerative process.
With age, changes can occur not only within stem cells themselves but also in niche components such as the extracellular matrix, neighboring cells, inflammatory signals and the systemic environment. Age-related follicle change therefore should not be reduced to a single protein or a single hormone.
A 2026 review of Collagen XVII also notes an association between aging, lower COL17A1 levels and increased proteolytic processing, while emphasizing important remaining gaps in humans regarding mechanism attribution, durable functional restoration and clinical target validation.
Does Acetyl Tetrapeptide-3 Increase Collagen XVII?
Current evidence does not support making that claim. Reported preclinical extracellular-matrix findings for Acetyl Tetrapeptide-3 relate to Collagen III and laminin in human fibroblasts and Collagen VII in human skin explants. These are not Collagen XVII.
Therefore, the presence of Acetyl Tetrapeptide-3 in Mirissa Lab serum does not mean that the product increases COL17A1 synthesis, renews the hair-follicle stem-cell niche or reverses biological follicle aging. Such a claim would require appropriate direct product-level clinical evidence.
Read the detailed guide to Acetyl Tetrapeptide-3 →
Menopause and Age-Related Hair Changes
The hair follicle is a hormone-sensitive tissue. During the menopausal transition, changes in estrogen production and shifts in the relative androgen environment may be associated in some women with changes in hair density, hair-shaft diameter, texture and the hair cycle.
However, a one-step explanation such as “estrogen falls, DHT pressure automatically rises and hair falls out” is inadequate. Conditions including female-pattern hair loss, telogen effluvium and frontal fibrosing alopecia may be seen more often after menopause, and their diagnosis and treatment are outside the scope of cosmetic care.
Oxidative Stress and Cellular Aging
DNA damage, oxidative stress, cellular senescence and inflammatory signaling are among the mechanisms studied in hair-follicle aging. These mechanistic relationships do not mean that a cosmetic antioxidant or care ingredient directly stops stem-cell aging.
For this reason, the role of an ingredient such as Niacinamide in NAD+ biology should not be extrapolated into product claims such as “prevents follicular senescence” or “rejuvenates stem cells through SIRT1.” In the Mirissa formulation, Niacinamide is considered within cosmetic care focused on scalp barrier support, moisture and the appearance of sebum balance.
Is Microcirculation the Only Cause of Aging?
No. The vascular network surrounding the follicle is a real part of hair biology, and the vascular environment can change with age. But explaining age-related hair thinning simply as “blood circulation decreases and the follicle is no longer nourished” is an excessive scientific simplification.
Likewise, Mirissa does not claim that scalp massage or Niacinamide “restores age-related loss of microcirculation.” Massage can be used as an application step to help distribute the serum gently across the scalp.
Read the guide to microcirculation and scalp massage →
How Is Mirissa Lab Scalp Serum Positioned in This Context?
Mirissa Lab Scalp Serum is formulated to provide regular cosmetic scalp care, not to treat biological aging or a hair-loss disorder.
- Niacinamide: supports cosmetic care focused on the scalp barrier, moisture and sebum appearance.
- Zinc PCA: is a care ingredient that supports a balanced-looking sebum profile for oily-prone scalp.
- Panthenol: contributes to moisture support and hair-fiber care.
- Acetyl Tetrapeptide-3, Biotinoyl Tripeptide-1, Apigenin and Oleanolic Acid: are components of the formula’s multi-active, peptide-based scalp-care architecture. Their presence alone does not establish stem-cell regeneration, increased Collagen XVII or new hair formation.
The product’s defensible cosmetic goal is to support a well-cared-for, comfortable scalp and help hair prone to shedding look stronger, fuller and well cared for.
Apply the serum to clean, dry or slightly damp scalp by parting the hair into sections; distribute gently with the fingertips and leave on without rinsing.
Explore Mirissa Lab Scalp Serum →
Can Scalp Aging Be Slowed?
Basic skin-care principles such as gentle cleansing, appropriate moisture support, avoiding unnecessary irritation and sun protection are meaningful for maintaining general scalp health. However, current Mirissa product data do not establish that a cosmetic scalp-care routine prevents Collagen XVII loss, preserves the stem-cell pool or clinically slows the biological aging rate of the follicle.
This distinction matters: care that supports healthy aging and reversing a biological aging mechanism are not the same claim.
Frequently Asked Questions
Can aging affect the appearance of hair?
Yes. Hair density, shaft diameter, pigmentation and the hair cycle can change with age. However, significant hair loss may have causes other than aging.
Why is Collagen XVII important to the hair follicle?
Collagen XVII is an important structural and signaling component associated with maintenance of the niche that contains hair-follicle stem cells. Experimental studies have linked COL17A1 loss with stem-cell aging and follicle miniaturization.
Does Acetyl Tetrapeptide-3 increase Collagen XVII production?
Current evidence does not support that claim. Reported preclinical ECM findings for the peptide involve Collagen III, Collagen VII and laminin; these are not the same protein as Collagen XVII.
Does Mirissa serum rejuvenate stem cells?
We do not make that claim. The serum is positioned for cosmetic scalp care and to help hair prone to shedding look stronger, fuller and well cared for.
Is hair loss during menopause normal?
Changes in hair density, shaft diameter and texture can occur during the menopausal transition, but sudden, marked or progressive loss should not automatically be attributed to hormones. Female-pattern hair loss, telogen effluvium and other conditions may require dermatological evaluation.
Can age-related hair loss be completely reversed?
That cannot be stated generally. The outcome depends on the underlying cause, the condition of the follicle and whether a medical hair disorder is present. Cosmetic care does not replace medical treatment.
When Should You See a Dermatologist?
New or rapidly increasing hair loss, marked thinning, patchy loss, eyebrow or eyelash loss, scalp pain, burning, persistent redness, crusting or sores warrant dermatological evaluation. In particular, hair loss that appears around menopause should not automatically be accepted as “normal aging.”
Scientific References
- Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science, 2016. PMID: 26912707.
- Collagen XVIIα1 in skin and hair aging: Mechanisms, stem cell niche regulation, and translational strategies. 2026. PMID: 42276855.
- Aging of hair follicle stem cells and their niches. 2023. PMID: 36379515.
- Menopause and hair loss in women: Exploring the hormonal transition. 2025. PMID: 40318238.
- Overview of Short Peptides for Hair Loss. 2026. PMID: 42072405.
This content is for informational purposes. Mirissa Lab products are cosmetic care products and do not replace medical diagnosis or treatment.
